188 related articles for article (PubMed ID: 16296724)
1. Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy.
Yew NS; Cheng SH
Expert Opin Drug Deliv; 2004 Nov; 1(1):115-25. PubMed ID: 16296724
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of cationic lipid-DNA complexes.
Yew NS; Scheule RK
Adv Genet; 2005; 53():189-214. PubMed ID: 16240994
[TBL] [Abstract][Full Text] [Related]
3. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs.
Yew NS; Zhao H; Wu IH; Song A; Tousignant JD; Przybylska M; Cheng SH
Mol Ther; 2000 Mar; 1(3):255-62. PubMed ID: 10933941
[TBL] [Abstract][Full Text] [Related]
4. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.
Hyde SC; Pringle IA; Abdullah S; Lawton AE; Davies LA; Varathalingam A; Nunez-Alonso G; Green AM; Bazzani RP; Sumner-Jones SG; Chan M; Li H; Yew NS; Cheng SH; Boyd AC; Davies JC; Griesenbach U; Porteous DJ; Sheppard DN; Munkonge FM; Alton EW; Gill DR
Nat Biotechnol; 2008 May; 26(5):549-51. PubMed ID: 18438402
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids.
Ratanamart J; Huggins CG; Kirby JA; Shaw JA
J Gene Med; 2007 Aug; 9(8):703-14. PubMed ID: 17595049
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of cationic lipid complexed with immunostimulatory DNA.
Rudginsky S; Siders W; Ingram L; Marshall J; Scheule R; Kaplan J
Mol Ther; 2001 Oct; 4(4):347-55. PubMed ID: 11592838
[TBL] [Abstract][Full Text] [Related]
7. The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector.
Pasquini S; Deng H; Reddy ST; Giles-Davis W; Ertl HC
Gene Ther; 1999 Aug; 6(8):1448-55. PubMed ID: 10467369
[TBL] [Abstract][Full Text] [Related]
8. The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model.
Yonenaga Y; Mori A; Fujimoto A; Nagayama S; Tachibana T; Onodera H; Uemoto S
J Gene Med; 2007 Apr; 9(4):299-307. PubMed ID: 17397091
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable polymers as non-viral carriers for plasmid DNA delivery.
Luten J; van Nostrum CF; De Smedt SC; Hennink WE
J Control Release; 2008 Mar; 126(2):97-110. PubMed ID: 18201788
[TBL] [Abstract][Full Text] [Related]
10. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
[TBL] [Abstract][Full Text] [Related]
11. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
[TBL] [Abstract][Full Text] [Related]
12. Innate immune response induced by gene delivery vectors.
Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
[TBL] [Abstract][Full Text] [Related]
13. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model.
Bertin S; Anjuere F; Gavelli A; Baque P; Soilihi BK; Brossette N; Loubat A; Pierrefite-Carle V
Int J Mol Med; 2008 Mar; 21(3):309-15. PubMed ID: 18288378
[TBL] [Abstract][Full Text] [Related]
14. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.
Bessis N; GarciaCozar FJ; Boissier MC
Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952
[TBL] [Abstract][Full Text] [Related]
15. Contribution of CpG motifs to the immunogenicity of DNA vaccines.
Klinman DM; Yamshchikov G; Ishigatsubo Y
J Immunol; 1997 Apr; 158(8):3635-9. PubMed ID: 9103425
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
Chaung HC
Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of CpG motifs in endoflagellar gene (flaB2) and expression vector (VR1012) of leptospiral DNA vaccine].
Dai B; You Z; He P; Wang M; Wang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):1-4. PubMed ID: 15600164
[TBL] [Abstract][Full Text] [Related]
18. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.
Chen Y; Lenert P; Weeratna R; McCluskie M; Wu T; Davis HL; Krieg AM
Gene Ther; 2001 Jul; 8(13):1024-32. PubMed ID: 11438837
[TBL] [Abstract][Full Text] [Related]
19. In vitro assay of immunostimulatory activities of plasmid vectors.
Jiang W; Reich CF; Pisetsky DS
Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
[TBL] [Abstract][Full Text] [Related]
20. Construction of a recombinant plasmid containing multi-copy CpG motifs and its effects on the innate immune responses of aquatic animals.
Chen Y; Xiang LX; Shao JZ
Fish Shellfish Immunol; 2007 Sep; 23(3):589-600. PubMed ID: 17475508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]